All stock lists
ImageneBio, Inc. (NASDAQ:IMA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
4.04-0.17 (-4.15%)
Insider Score
––Not scored
IMA Insider Score
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
IMA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 800.00 K |
| Revenue Growth (YoY) | — | -100.00 % | — | — | — | — |
| Cost of Revenue | 0.00 | 174.00 K | 561.00 K | 0.00 | 45.00 K | 0.00 |
| Gross Profit | 0.00 | -174.00 K | -561.00 K | 0.00 | -45.00 K | 800.00 K |
| SG&A Expense | 5.12 M | 6.12 M | -370.00 K | 11.04 M | 4.42 M | 2.75 M |
| R&D Expense | 6.67 M | 5.96 M | 5.23 M | 15.56 M | 4.03 M | 4.04 M |
| Operating Expenses | 11.78 M | 11.90 M | 7.94 M | 26.59 M | 8.71 M | 6.79 M |
| Operating Income | -11.78 M | -12.08 M | -8.50 M | -26.59 M | -8.75 M | -6.00 M |
| Pretax Income | -10.16 M | -10.61 M | -7.18 M | -24.85 M | -2.75 M | -6.08 M |
| Tax Provision | 16.00 K | 10.00 K | -276.00 K | -74.00 K | 15.00 K | 0.00 |
| Net Income | -10.18 M | -10.62 M | -6.91 M | -24.78 M | -2.77 M | -6.08 M |
| EPS (Basic) | -0.63 | -0.95 | -0.62 | -3.01 | -4.46 | -6.47 |
| EPS (Diluted) | -0.63 | -0.95 | -0.62 | -3.01 | -4.46 | -6.47 |
| Shares Outstanding | 16.16 M | 11.21 M | 11.18 M | 8.53 M | 2.41 M | 1.41 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.